Skyward Specialty Insurance Group has just crossed its Q2 earnings release with the bullish options setup from yesterday's preview still intact — now the question is whether the post-print data reshapes the positioning story or simply confirms it.
The options market remains strikingly one-sided. Call activity is heavily dominating put buying: the put/call ratio is 0.35, more than 2.5 standard deviations below its 20-day average of 0.59. That is near the lowest defensive reading of the past year, and it has held at these extremes for two consecutive sessions. The contrast with late June is sharp — the PCR ran between 1.2 and 1.3 then, reflecting genuine hedging demand. That hedging has since unwound almost entirely. The borrow market adds little drama to the picture. Availability is extremely loose at roughly 1,644% — meaning there are more than sixteen shares available to borrow for every one currently lent out, well above even the 52-week floor of around 1,027%. Cost to borrow has eased about 18% on the week to just 0.39%, close to its cheapest level of the past two months.
Short interest reinforces the unagitated tone. Bears have been cutting positions steadily: SI has fallen roughly 15% in the past month to 4.3% of free float, down from a peak near 2.5 million shares in early July to around 1.76 million. That is not a crowded short by any measure, and with borrow this cheap and availability this wide, there is no mechanical squeeze pressure. The ORTEX short score of 40 ranks in the 32nd percentile — firmly in the lower half — consistent with a stock where short-side conviction has been waning rather than building.
The Street has been methodical in upgrading conviction into this print. Barclays raised its target again this morning to $68, maintaining Overweight — the firm's third upward revision in four months. Piper Sandler and Keefe, Bruyette & Woods both carry $72 targets with positive ratings after mid-July upgrades. The consensus mean now sits near $65, implying modest upside from $61.57 — but those targets were set before today's numbers land. The bull case centres on disciplined underwriting, the Apollo Group acquisition, and specialty market partnerships including Uber; bears flag catastrophe exposure, ESG regulatory risk, and the mixed trajectory on net investment income. The PE multiple has compressed slightly over the past month to around 11.5x, and price-to-book has eased to roughly 1.88x — neither particularly stretched for a specialty insurer delivering the growth profile the bulls are describing.
Institutional ownership shows active accumulation into Q2. T. Rowe Price added roughly 826,000 shares in the quarter ending June 30, taking its stake to nearly 5% of shares. BlackRock added over 500,000 shares in the same period. Wasatch Advisors built a new position of around 635,000 shares. Reinhart Partners, already the second-largest institutional holder at 7.1%, added incrementally. That is a broad-based inflow from multiple institutions in a single quarter — notably not concentrated in one name.
With the Q2 results now in hand, the next scheduled event is November 5. The gap between the current price and the evolving consensus target — and whether today's print prompts further target revisions from the analysts who have been consistently raising numbers — is worth tracking over the coming sessions.
See the live data behind this article on ORTEX.
Open SKWD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
